title: Therapeutic effect of gevilon in patients with hyperlipoproteinaemia.
abstract: Authors examined 46 patients with hyperlipoproteinaemia divided according to hyperlipoproteinaemia type II A, II B, IV. After one month of isocaloric diet the patients were given a single night gevilon dose of 900 mg for a period of 3 months. After therapy we examined lipid metabolism, liver and kidney function, carbohydrate metabolism, hematopoietic system and water--electrolyte balance. In all groups increased levels of cholesterol, beta-lipoproteins and triglycerides were significantly reduced after 3 months of gevilon treatment. In all patients the HDL/LDL ratio increased close to normal values. No impairment of kidney or liver function hematopoietic system and electrolyte balance after 3 months of treatment were noted. Because gevilon is easy to apply and has a limited number of side effects, it is very readily taken by the patients who have lipid balance disorders.
authors.affiliation: Department of Endocrinology, Medical Academy, Wrocław, Poland.
authors.forename: A
authors.initials: A
authors.lastname: Milewicz
authors.forename: Z
authors.initials: Z
authors.lastname: Plamieniak
authors.forename: A
authors.initials: A
authors.lastname: Bohdanowicz-Pawlak
mesh_terms: D000085:Acetates / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D003509:Cyclohexanecarboxylic Acids; D005260:Female; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D000085:Acetates; D003509:Cyclohexanecarboxylic Acids; C082676:gevilon